NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

1. Ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of ursodiol […]

NH2-PEGn-PA is a non-cleavable PEG-containing ADC linker for the development of antibody-coupled drugs (ADCs).

1. Ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of ursodiol […]

Sotalol hydrochloride tablets (AF) are indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (AFIB/AFL)] in patients with symptomatic AFIB/AFL who are currently in sinus rhythm. Because sotalol hydrochloride tablets (AF) can cause life-threatening ventricular arrhythmias, it should be reserved for patients in whom AFIB/AFL is highly […]